Back to search

University of South Florida

Combating β-lactamase Resistance: From Inhibitor Design to Substrate Evolution

Abstract

dc:description

β-lactamase production by bacteria is a major mechanism of antibiotic resistance. These enzymes hydrolyze β-lactam antibiotics, preventing them from binding to and inhibiting PBPs. Although new β-lactam scaffolds and inhibitors are continually introduced into the clinic, resistance often emerges within a few years. Therefore, the development of cross-class inhibitors with novel scaffolds is critical to mitigate this resistance. In parallel, a deeper understanding of the structural and mechanistic basis of β-lactamase resistance is essential. Together, these approaches provide an effective strategy for combating antibiotic resistance. The first project addressed the need of effective cross-class β-lactamase inhibitors capable of targeting SBL and MBLs. The parent compound exhibited potent inhibition towards KPC-2 (Ki =20 nM) but weak activity against the MBL NDM-1 (Ki = 30 uM). Our objective was to optimize this scaffold to enhance NDM-1 inhibition while retaining SBL activity. Using a SAR approach, we introduced chemical modifications at multiple positions on the scaffold and obtained complex crystal structures to reveal key ligand-enzyme interactions that influenced compound design. This approach led to the development of an improved inhibitor against NDM-1 with a Ki of 1 uM, enhancing activity by approximately 30-fold. The second project focused on the evolution of substrate specificity in ESBLs and carbapenemases. Using a dynamic approach with NMR, we found that the G238S mutation in the ESBL TEM-1 reorganizes the active site, while secondary mutations optimize catalytic efficiency rather than stability. The combination of ESBL mutations collectively reshape active site walls and scaffold regions through epistatic interactions. In carbapenemases, multiple residues distributed across distinct structural elements were identified as critical for recovering carbapenem hydrolysis. Structural analysis revealed potential crosstalk between the β3-strand and omega-loop, suggesting that coordination modulates substrate specificity. By better understanding the evolution of substrate expansion in β-lactamases, these findings form a basis for the continual development of β-lactamase inhibitors to mitigate antibiotic resistance.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Medical Sciences
Grantor
University of South Florida
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Jacobs, Lian M.C.
Contributors dc:contributor
  • Yu Chen, Ph.D.
  • Robert Deschenes, Ph.D.
  • Sophie Darch, Ph.D.
  • Lindsey Shaw, Ph.D.

Subjects

dc:subject × 7

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/11314

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Jacobs, Lian M.C.. Combating β-lactamase Resistance: From Inhibitor Design to Substrate Evolution. Dissertation thesis, University of South Florida, 2026. https://digitalcommons.usf.edu/etd/11314